Glaxosmithkline Pharmaceuticals Ltd. (GLAXO): Glaxosmithkline Pharmaceuticals Share Price Hits Fresh 52-Week High
- August 28, 2026
- Posted by: Harsh Piplani
- Category: News
Glaxosmithkline Pharmaceuticals Share Price was Rs 3,098.45 on 28 August 2026 at 12:26 PM IST, up 0.98% for the day, after touching a fresh 52-week high of Rs 3,116. The company’s market capitalisation stood at Rs 51,287.68 crore. The latest GLAXO Share Price movement is relevant because it sets a new yearly high within the available data and places the stock among the day’s notable stocks in news on the Indian stock market.
The move is confirmed by the day’s range and the session high, while the supplied data does not establish a company-specific catalyst. Univest records the event as a fresh 52-week high, and the price action can therefore be read as a verified share price update rather than a reason-led move. For readers tracking GLAXO Share Price Today, the session also offers a clear reference point for stock analysis, market capitalisation and sector comparison.
Glaxosmithkline Pharmaceuticals Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 3,098.45 |
| Previous Close | Rs 3,068.35 |
| Today's Move | +Rs 30.1 (+0.98%) |
| Open | Rs 3,082.05 |
| High | Rs 3,116 |
| Low | Rs 3,066 |
| Turnover | Rs 0.4 crore |
| Market Capitalisation | Rs 51,287.68 crore |
Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) traded at Rs 3,098.45 versus the previous close of Rs 3,068.35, a rise of 0.98%. The stock opened at Rs 3,082.05, reached a high of Rs 3,116 and touched a low of Rs 3,066.
Glaxosmithkline Pharmaceuticals Share Price opened at Rs 3,082.05, traded between Rs 3,066 and Rs 3,116, and closed the latest reading at Rs 3,098.45 versus the previous close of Rs 3,068.35. That is a rise of Rs 30.10, or 0.98%, for the session. The stock touched Rs 3,116, which is also its fresh 52-week high and the day’s high.
The session turnover stood at Rs 0.4 crore. With the current price finishing close to the day’s top end, the price action confirms a fresh yearly high in GLAXO Share Price Today terms. For investors following Glaxosmithkline Pharmaceuticals Share Price Live and GLAXO Share Price News, the key facts are the higher close, the new 52-week peak and the narrow gap between the session high and the current reading.
This is the main price-led reason the stock is appearing in searches for Glaxosmithkline Pharmaceuticals Stock News, 52 Week High Stocks and Stocks in News today. The next step is to place that movement in the context of fundamentals and sector valuation.
Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 51,287.68 crore |
| P/E Ratio | 48.66x |
| P/B Ratio | 20.62x |
| ROE | 48.76% |
| ROCE | 66.79% |
| EPS | Rs 63.05 |
| Book Value Per Share | Rs 148.77 |
| Dividend Yield | 1.86% |
Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) fundamental metrics show P/E 48.66x, P/B 20.62x, ROE 48.76%, ROCE 66.79%. These figures provide context only and are not a buy or sell signal.
Glaxosmithkline Pharmaceuticals Ltd. has a market capitalisation of Rs 51287.68 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 48.66x, P/B at 20.62x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 48.76% and ROCE of 66.79%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 63.05, book value per share of Rs 148.77, dividend yield of 1.86%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 31.15x, median ROE of 11.81%, median ROCE of 13.68%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 48.66x |
| Benchmark Median P/E | 31.15x |
| Benchmark Average P/E | 48.04x |
| Benchmark P/E Range | 3.36x to 397.25x |
| Company P/B Ratio | 20.62x |
| Benchmark Median P/B | 2.64x |
| Company ROE | 48.76% |
| Benchmark Median ROE | 11.81% |
| Company ROCE | 66.79% |
| Benchmark Median ROCE | 13.68% |
| Company Market Capitalisation | Rs 51,287.68 crore |
| Benchmark Median Market Cap | Rs 633.24 crore |
Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) has a P/E ratio of 48.66x, which is above the benchmark median of 31.15x, a difference of +56.21%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) has a ROE of 48.76%, which is above the benchmark median of 11.81%, a difference of +312.87%. Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) has a ROCE of 66.79%, which is above the benchmark median of 13.68%, a difference of +388.23%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Anthem Biosciences Ltd. | ANTHEM | 52,027.91 | 90.39 | 16.64 | 21.98 | 29.62 |
| Ipca Laboratories Ltd. | IPCALAB | 49,520.53 | 37.94 | 5.86 | 15.88 | 19.41 |
| Gland Pharma Ltd. | GLAND | 47,931.89 | 41.99 | 4.46 | 10.56 | 14.96 |
| Abbott India Ltd. | ABBOTINDIA | 56,313.09 | 34.71 | 10.83 | 34.67 | 46.72 |
| Ajanta Pharma Ltd. | AJANTPHARM | 44,299.85 | 38.99 | 9.11 | 25.42 | 32.67 |
Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) has a P/E ratio of 48.66x compared with the displayed peer median of 38.99x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 48.76% compares with a peer median of 21.98% across the companies shown in the table. ROCE stood at 66.79% versus the displayed peer median of 29.62%, providing a capital-efficiency comparison. Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) has a market capitalisation of Rs 51,287.68 crore. Among the 5 peers shown, 2 have a larger market capitalisation.
Why Investors Are Watching Glaxosmithkline Pharmaceuticals
- Glaxosmithkline Pharmaceuticals Share Price touched a fresh 52-week high of Rs 3,116.
- The latest GLAXO Share Price reading was Rs 3,098.45, above the previous close of Rs 3,068.35.
- Market capitalisation stood at Rs 51,287.68 crore.
- P/E was 48.66, P/B was 20.62, ROE was 48.76% and ROCE was 66.79%.
- EPS was Rs 63.05, book value was Rs 148.77 and dividend yield was 1.86%.
About Glaxosmithkline Pharmaceuticals
Glaxosmithkline Pharmaceuticals Ltd. is classified under Healthcare and the Pharmaceuticals & Drugs industry. The supplied data identifies the company as GLAXO and places it within a benchmark universe of listed pharmaceutical names used for peer and sector comparison. For readers following GLAXO Share Price, this classification is the core business context available in the record.
Univest uses this company profile alongside price, valuation and benchmark data to present GLAXO Share Price Today in a broader stock analysis format. That is useful for readers comparing share price news, company news and sector context without moving beyond verified data.
Track Glaxosmithkline Pharmaceuticals Share Price on Univest
Use Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Readers can track Glaxosmithkline Pharmaceuticals Share Price on Univest for live share price updates, fundamental ratios, market capitalisation, shareholding pattern, 52-week levels and sector context. Univest also groups GLAXO Share Price with related stock news, company news and market insights for quick review.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is the current Glaxosmithkline Pharmaceuticals Share Price?
Ans. Glaxosmithkline Pharmaceuticals Share Price was Rs 3,098.45 in the latest reading. It was above the previous close of Rs 3,068.35 and sat close to the day’s high of Rs 3,116.
Did GLAXO hit a fresh 52-week high today?
Ans. Yes. GLAXO touched Rs 3,116, which is the fresh 52-week high and also the session high in the supplied data. That makes the event a verified one-year high rather than an all-time high claim.
How much did Glaxosmithkline Pharmaceuticals Share Price change today?
Ans. The stock rose Rs 30.10, or 0.98%, versus the previous close. The move took the share price from Rs 3,068.35 to Rs 3,098.45 in the latest update. The stock moved 0.98% during the session.
What is the market capitalisation of GLAXO?
Ans. Glaxosmithkline Pharmaceuticals had a market capitalisation of Rs 51,287.68 crore. That places it well above the benchmark median in the supplied healthcare industry snapshot. The company operates in the Healthcare sector.
How are GLAXO valuation ratios positioned?
Ans. GLAXO’s P/E is 48.66 and its P/B is 20.62. Both sit above the supplied industry medians, while ROE of 48.76% and ROCE of 66.79% are also well above benchmark levels.
What do EPS and book value show for GLAXO?
Ans. EPS is Rs 63.05 and book value is Rs 148.77. EPS reflects earnings per share, while book value shows accounting net worth per share and helps frame Glaxosmithkline Pharmaceuticals Share Price.
What sector does GLAXO belong to?
Ans. GLAXO belongs to Healthcare, specifically the Pharmaceuticals & Drugs industry. That sector context is central to GLAXO Share Price analysis and the peer comparison used in the article. The stock belongs to the Healthcare sector.
Which peers are used for GLAXO comparison?
Ans. The supplied peer set includes Anthem Biosciences, Ipca Laboratories, Gland Pharma, Abbott India and Ajanta Pharma. Their market cap and ratio data help place Glaxosmithkline Pharmaceuticals Share Price in context.
